Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.3700
+0.0200 (5.71%)
Sep 4, 2026, 2:47 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 12.96 million as of September 4, 2026. Its market cap has decreased by -57.49% in one year.
Market Cap
12.96M
Enterprise Value
11.76M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 12.96M, a decrease of -86.72%. That is a compound annual growth rate of -34.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.96M | -55.31% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 27.94M |
| SkinBioTherapeutics | 24.62M |
| ImmuPharma | 21.59M |
| Palatin Technologies | 18.24M |
| IXICO | 16.35M |
| Fusion Antibodies | 14.71M |
| Genflow Biosciences | 12.18M |
| Solvonis Therapeutics | 8.17M |